278 related articles for article (PubMed ID: 22818417)
1. Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?
Góra J; Stock M; Lütgendorf-Caucig C; Georg D
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):881-8. PubMed ID: 22818417
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
3. Robustness against interfraction prostate movement in scanned ion beam radiation therapy.
Jelen U; Ammazzalorso F; Chanrion MA; Gräf S; Zink K; Engenhart-Cabillic R; Wittig A
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e257-62. PubMed ID: 22677368
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
Marnouche EA; Hadadi K; Abdelhak M; Benlemlih M; Hommadi M; Zaghba N; Andaloussi Saghir K; Elmarjany M; Sifat H; Mansouri H
Cancer Radiother; 2021 Apr; 25(2):161-168. PubMed ID: 33454191
[TBL] [Abstract][Full Text] [Related]
5. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
Outaggarts Z; Wegener D; Berger B; Zips D; Paulsen F; Bleif M; Thorwarth D; Alber M; Dohm O; Müller AC
Acta Oncol; 2020 Aug; 59(8):911-917. PubMed ID: 32436467
[No Abstract] [Full Text] [Related]
6. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
7. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning.
Tang S; Deville C; Tochner Z; Wang KK; McDonough J; Vapiwala N; Both S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1186-94. PubMed ID: 25442043
[TBL] [Abstract][Full Text] [Related]
8. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans.
Bondar ML; Hoogeman MS; Mens JW; Quint S; Ahmad R; Dhawtal G; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1617-23. PubMed ID: 22270164
[TBL] [Abstract][Full Text] [Related]
9. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
[TBL] [Abstract][Full Text] [Related]
10. Effect of accounting for interfractional CTV shape variations in PTV margins on prostate cancer radiation treatment plans.
Hirose TA; Arimura H; Shibayama Y; Fukunaga JI; Ohga S
Phys Med; 2018 Oct; 54():66-76. PubMed ID: 30337012
[TBL] [Abstract][Full Text] [Related]
11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
12. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
13. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
[TBL] [Abstract][Full Text] [Related]
14. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
[TBL] [Abstract][Full Text] [Related]
15. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
[TBL] [Abstract][Full Text] [Related]
16. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
[TBL] [Abstract][Full Text] [Related]
17. Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical cancer.
Tyagi N; Lewis JH; Yashar CM; Vo D; Jiang SB; Mundt AJ; Mell LK
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):273-80. PubMed ID: 21109360
[TBL] [Abstract][Full Text] [Related]
18. Statistical modeling of CTV motion and deformation for IMRT of early-stage rectal cancer.
Bondar L; Intven M; Burbach JP; Budiarto E; Kleijnen JP; Philippens M; van Asselen B; Seravalli E; Reerink O; Raaymakers B
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):664-72. PubMed ID: 25151540
[TBL] [Abstract][Full Text] [Related]
19. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
